Gracell Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRCL and buy or sell other stocks, ETFs, and their options commission-free!About GRCL
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer.
CEOWei Cao, PhD
CEOWei Cao, PhD
Employees—
Employees—
HeadquartersSuzhou, Shanghai
HeadquartersSuzhou, Shanghai
Founded2017
Founded2017
Employees—
Employees—
GRCL Key Statistics
Market cap983.25M
Market cap983.25M
Price-Earnings ratio-10.08
Price-Earnings ratio-10.08
Dividend yield—
Dividend yield—
Average volume930.52K
Average volume930.52K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.44
52 Week high$10.44
52 Week low$1.40
52 Week low$1.40
Stock Snapshot
The current Gracell Biotechnologies(GRCL) stock price is $10.25, with a market capitalization of 983.25M. The stock trades at a price-to-earnings (P/E) ratio of -10.08.
On 2025-12-15, Gracell Biotechnologies(GRCL) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Gracell Biotechnologies(GRCL) stock has reached 0, versus its average volume of 930.52K.
The stock's 52-week range extends from a low of $1.40 to a high of $10.44.
The stock's 52-week range extends from a low of $1.40 to a high of $10.44.